Navigation Links
MSU targets women's health research with $2.5 million grant

EAST LANSING, Mich. - With the help of a $2.5 million grant from the National Institutes of Health, Michigan State University is creating a cross-discipline, mentored program designed to increase the number and diversity of researchers in women's health.

MSU's new Building Interdisciplinary Research Careers in Women's Health program, to be housed in the Department of Medicine in the College of Human Medicine, will help junior investigators by matching them with mentors and protecting their time so they can focus on research efforts.

Investigators from across the university researching women's health will be eligible to apply for the program.

"This award provides an enormous opportunity for MSU and researchers in women's health," said Mary Nettleman, chairperson of the Department of Medicine and principal investigator on the grant. "This type of training grant not only encourages young investigators to come to MSU but also creates new networks and connections among researchers.

"It allows scholars to become independently funded women's health investigators."

As part of the program, junior investigators from disciplines across the university can apply for funding. Those chosen will be assigned to a mentor; 21 mentors have been identified from the colleges of Human Medicine, Osteopathic Medicine, Natural Science, Veterinary Medicine, Nursing, Social Science and Communication Arts and Sciences.

Also, the grant will help cover the salaries of junior investigators to allow them time to apply for grants, set up projects and conduct research.

"For these researchers, the commodity most difficult to get is time," Nettleman said, noting that departments will be reimbursed so investigators can focus solely on research projects. "This will help ensure that promising junior researchers have the protected time, good mentorship and appropriate training to become successful women's health researchers."

In addition to mentoring and resources, the program includes a curriculum tailored to the specific stage of development of each scholar, she added, noting this will support scholars at a time in their career where they are at highest risk to leave research.

The grant solidifies MSU as innovators in women's health research. In April, MSU's College of Human Medicine became the home for a $6.8 million Center for Women's Health and Reproduction Research, led by infertility researcher Asgi T. Fazleabas. MSU also is home to the Breast Cancer and the Environment Research Center, established in 2003 and led by physiology professor Sandra Z. Haslam. The center studies the impact of prenatal-to-adult environmental exposures that predispose women to breast cancer.

Nettleman said one of the reasons NIH chose MSU as one of 12 grant recipients nationwide was the strength of its current research profile, as well as the university's diversity among investigators and projects.

An application process is being developed, Nettleman said, and information will be sent to researchers in the coming weeks. The program will sponsor approximately eight scholars over the life of the grant. By the end of the training period, each scholar is expected to have written a competitive grant application.


Contact: Jason Cody
Michigan State University

Related medicine news :

1. Researcher targets gene regulators on link between arsenic, cancer
2. Miami meeting on radiation therapy targets patient safety
3. Combination therapy targets stubborn leukemia stem cells
4. Global Summit on International Breast Health Targets Breast Health Improvements in Developing Countries, June 9-11, 2010, in Chicago
5. FDA Targets Safety Problems With Infusion Drug Pumps
6. Global Leader Readied For Healthy Aging Boom, Targets Wall Street With New Center In Trump Building
7. Scott & White Healthcare researchers studying investigational agent that targets breast cancer
8. Hot Pepper Itch Remedy Targets Kidney Disease Patients Suffering From Chronic Pruritus
9. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
10. More Women to Get Health Insurance Under Affordable Care Act
11. 30 million women to benefit from health reform law
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: